Biotech Medics (BMCS) Stock Price, News & Analysis
Company Description
Biotech Medics (OTC Link: BMCS) is classified in the drug manufacturers - specialty & generic industry within the Healthcare sector and carries a market capitalization of $1.7M.
BMCS has declined 99.3% over the past year. Shares last traded at $0.0001.
This page collects what Stock Titan holds for BMCS, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Biotech Medics (BMCS) stock last closed at $0.0001. Over the past 12 months, the stock has lost 99.3%. At a market capitalization of $1.7M, BMCS is classified as a micro-cap stock with approximately 205.4M shares outstanding.
Latest News
Biotech Medics has 10 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 2 with negative movement. Key topics include acquisition, crypto. View all BMCS news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Biotech Medics (BMCS) currently stands at 9.2 thousand shares, representing 0.0% of the float. This relatively low short interest suggests limited bearish sentiment. The 7.2 days to cover indicates moderate liquidity for short covering.
Days to Cover History
Days to cover for Biotech Medics (BMCS) currently stands at 7.2 days, up 383.8% from the previous period. This moderate days-to-cover ratio suggests reasonable liquidity for short covering, requiring about a week of average trading volume. The days to cover has increased 477.4% over the past year, indicating either rising short interest or declining trading volume. The ratio has shown significant volatility over the period, ranging from 1.0 to 1000.0 days.
BMCS Company Profile & Sector Positioning
Biotech Medics (BMCS) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing BMCS often look at related companies in the same sector, including Aion Therapeutic (ANTCF), Sibannac (SNNC), Software Effective Solutions (SFWJ), Galexxy Holdings Inc (GXXY), and STEMTECH CORPORATION (STEK). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate BMCS's relative position within its industry.